Cite
HARVARD Citation
Moors, I. et al. (2019). Clinical implications of measurable residual disease in AML: Review of current evidence. Critical reviews in oncology/hematology. pp. 142-148. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moors, I. et al. (2019). Clinical implications of measurable residual disease in AML: Review of current evidence. Critical reviews in oncology/hematology. pp. 142-148. [Online].